Summary:
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Serial Cohort Dose Escalation Study to Assess The Safety, Tolerability, And Pharmacokinetics Of Single Oral Doses of AT-1082 In Healthy Nonsmoking And Smoking Adults.
- Be 18-55 years old
- Have a BMI of 18-32 kg/m2
- Smoke 1 pack of cigarettes or more per day
- Be in good health, with no medications
Qualified Participants May Receive:
- Up to $1,525 for time and travel.
- Tranportation provided and no insurance needed.